Day One Biopharmaceuticals develops targeted therapies for pediatric cancer patients, striving to improve treatment outcomes and ultimately extend these benefits to patients of all ages. The company's mission specifically focuses on identifying and clinically evaluating novel drug candidates to address unmet medical needs in oncology. Day One emphasizes a collaborative and mission-driven culture to foster innovation and expedite the drug development process. Adhering to values such as respect, integrity, and transparency, Day One promotes an inclusive workplace where diverse perspectives are valued. The company actively engages with external stakeholders, including regulatory agencies, to ensure high standards in their clinical research and meet the needs of patients and healthcare providers.